Last reviewed · How we verify
Grazoprevir plus Elbasvir
Grazoprevir plus Elbasvir is a Small molecule drug developed by Kyushu University. It is currently FDA-approved.
Grazoprevir plus Elbasvir is a small molecule combination treatment used to study various conditions, including Hepatitis C, HIV, and Cardiovascular Diseases, as per ClinicalTrials.gov. The combination is available in a fixed-dose form, specifically Grazoprevir 100 mg/Elbasvir 50 mg tablets, as per ClinicalTrials.gov.
At a glance
| Generic name | Grazoprevir plus Elbasvir |
|---|---|
| Sponsor | Kyushu University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pembrolizumab (MK-3475) in Hepatocellular Carcinoma (PHASE2)
- Zepatier in Patients with Substance Use
- HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant (PHASE4)
- Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients (PHASE1, PHASE2)
- Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079) (PHASE2)
- Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication (PHASE4)
- ATTIC - Access To Treat in the Community (PHASE4)
- Transplanting Hepatitis C Lungs Into Negative Lung Recipients (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Grazoprevir plus Elbasvir CI brief — competitive landscape report
- Grazoprevir plus Elbasvir updates RSS · CI watch RSS
- Kyushu University portfolio CI
Frequently asked questions about Grazoprevir plus Elbasvir
What is Grazoprevir plus Elbasvir?
Who makes Grazoprevir plus Elbasvir?
What development phase is Grazoprevir plus Elbasvir in?
Related
- Manufacturer: Kyushu University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing